Date Posted: 01 - February - 2018
BNF chapter: Endocrine system Musculoskeletal system
Denosumab as a second-line treatment option for the prevention of Osteoporotic Fragility Fractures
Date Posted: 19 - March - 2021
BNF chapter: Endocrine system
Please note: GPs and other primary care prescribers are under no obligation to act upon the advice issued by a private specialist. If the NHS prescriber receiving the request does not believe they have the competence to initiate or continue the recommended intervention a referral to an appropriate NHS specialist should be made. Patients are entitled to receive additional private care if this is provided separately from NHS care.